Stock data
Moderna, Inc. (MRNA)
Moderna, Inc. (MRNA) reported revenue of US$1.94B and net income of -US$2.82B for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$1.94B | — | -US$3.07B | -US$2.82B | — |
| 2024 | US$3.24B | — | -US$3.94B | -US$3.56B | — |
| 2023 | US$6.85B | — | -US$4.24B | -US$4.71B | — |
| 2022 | US$19.26B | — | US$9.42B | US$8.36B | — |
| 2021 | US$18.47B | — | US$13.30B | US$12.20B | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$145.00M | -US$782.00M | — |
| 2026-03-31 | US$389.00M | -US$1.34B | — |
| 2025-12-31 | US$678.00M | -US$826.00M | — |
| 2025-09-30 | US$1.02B | -US$200.00M | — |
| 2025-06-30 | US$142.00M | -US$825.00M | — |
| 2025-03-31 | US$108.00M | -US$971.00M | — |
| 2024-12-31 | US$966.00M | -US$1.12B | — |
| 2024-09-30 | US$1.86B | US$13.00M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.